Cargando…
Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review
Fibroblast growth factor receptor-2 (FGFR2) gene is amplified in up to 15% of patients with gastric cancer (GC). However, the prognostic significance of FGFR2 amplification has been controversial. This meta-analysis was conducted to evaluate the clinicopathological impacts of FGFR2 amplification in...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584337/ https://www.ncbi.nlm.nih.gov/pubmed/31258762 http://dx.doi.org/10.7150/jca.29184 |